Heart failure trials in Bulgaria
21 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Burgas, Haskovo, Plovdiv, Sofia, Veliko Tarnovo, Yambol
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Burgas, Dimitrovgrad, Gotse Delchev, Kirdzhali, Kyustendil, Pernik, Pleven, Plovdiv, Ruse, Sofia, Sofiya, Stara Zagora, Varna, Veliko Tirnovo, Yambol
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Burgas, Dimitrovgrad, Gabrovo, Gotse Delchev, Kirdzhali, Kyustendil, Pazardzhik, Pernik, Pleven, Plovdiv, Ruse, Sofia, Sofiya, Stara Zagora, Veliko Tirnovo, Yambol
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Burgas, Haskovo, Plovdiv, Sofia, Sofiya, Veliko Tirnovo, Yambol
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Plovdiv, Sofia, Sofiya
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - Phase 2Taking peopleA Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Where
- Blagoevgrad, Gabrovo, Kyustendil, Lom, Pleven, Plovdiv, Sliven, Sofia, Sofiya
- Age
- 18 years to 79 years
- People
- 620 worldwide
- Run by
- Pfizer
See details and how to joinNCT06991257 · EU 2024-518438-94-00 - Phase 3Taking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Haskovo, Panagyurishte, Pleven, Plovdiv, Ruse, Shumen, Sofia, Sofiya, Stara Zagora, Varna
- Age
- 40 years and over
- People
- 11,300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Plovdiv, Sofia, Sofiya
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Botevgrad, Dupnitsa, Haskovo, Kozloduy, Pleven, Plovdiv, Sliven, Sofia, Stara Zagora
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - Phase 3Taking peopleMulti-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- Where
- Blagoevgrad, Burgas, Gabrovo, Haskovo, Pleven, Plovdiv, Sofia, Sofiya, Veliko Tirnovo
- Age
- 18 years and over
- People
- 1,900 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT06929806 · EU 2024-519059-28-00 - Phase 3Taking peopleA Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Blagoevgrad, Dupnitsa, Haskovo, Plovdiv, Sliven, Sofia, Varna
- Age
- 18 years and over
- People
- 6,950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117 · EU 2026-526304-79-00 - Phase 2Not yet taking people in BulgariaA Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
- Where
- Blagoevgrad, Burgas, Lovech, Pleven, Sofia, Stara Zagora
- Age
- 18 years to 85 years
- People
- 400 worldwide
- Run by
- AnaCardio AB
See details and how to joinNCT07584967 · EU 2025-524469-25-00 - No phaseTaking peoplePacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
- Where
- Sofia
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT07276139 - Phase 3Taking peopleA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Where
- Gotse Delchev, Haskovo, Sofia, Varna
- Age
- 18 years and over
- People
- 5,200 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06008197 - No phaseEnrolling by invitationSnapshot Study on Patients With Heart Failure
- Where
- Sofia, Stara Zagora, Varna
- Age
- 18 years and over
- People
- 4,000 worldwide
- Run by
- European Society of Cardiology
See details and how to joinNCT06469814 - Phase 2Not yet taking people in BulgariaA Phase 2, randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFREF) (CALIBRATE-HF)
- Where
- Burgas, Dimitrovgrad, Pazardzhik, Pernik, Plovdiv, Sofia, Varna, Veliko Tirnovo
- Age
- 18 years and over
- People
- 369 worldwide
- Run by
- Cardurion Pharmaceuticals Inc.
See details and how to join2025-525033-31-00 · EU 2025-525033-31-00 - Phase 3Taking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Burgas, Dimitrovgrad, Dobrich, Gotse Delchev, Kozloduy, Lom, Montana, Pleven, Plovdiv, Sofia, Sofiya, Stara Zagora, Varna, Veliko Tirnovo
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - No phaseTaking peopleAlleviant ALLAY-HF Study
- Where
- Plovdiv
- Age
- 40 years and over
- People
- 700 worldwide
- Run by
- Alleviant Medical, Inc.
See details and how to joinNCT05685303 - No phaseTaking peopleEarly Detection and IntervenTion in Heart Failure
- Where
- Sofia
- Age
- 65 years and over
- People
- 18,000 worldwide
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07731490 - No phaseTaking peopleIntegrated Approach in Frail Older People with Atrial Fibrillation
- Where
- Haskovo, Pernik, Plovdiv, Sofia
- Age
- 65 years and over
- People
- 1,250 worldwide
- Run by
- Heart Care Foundation
See details and how to joinNCT06775028 - No phaseTaking peopleAtrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
- Where
- Sofia
- Age
- 60 years and over
- People
- 220 worldwide
- Run by
- University Hospital, Geneva
See details and how to joinNCT06207383